SPC
WST icon

Sigma Planning Corp’s West Pharmaceutical WST Stock Holding History

Sigma Planning Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-619
Closed -$204K – 1283
2024
Q2 		$204K Sell
619
-2
-0.3% -$707 0.01% 1082
2024
Q1 		$246K Buy
+621
New +$230K 0.01% 1045
2023
Q4 		– Sell
-551
Closed -$207K – 1186
2023
Q3 		$207K Buy
+551
New +$213K 0.01% 1078
2023
Q2 		– Sell
-699
Closed -$242K – 1360
2023
Q1 		$242K Buy
+699
New +$204K 0.01% 1095
2021
Q1 		– Sell
-1,015
Closed -$288K – 1416
2020
Q4 		$288K Sell
1,015
-651
-39% -$183K 0.01% 918
2020
Q3 		$458K Buy
1,666
+210
+14% +$55.6K 0.02% 637
2020
Q2 		$331K Buy
+1,456
New +$286K 0.01% 742
2019
Q4 		– Sell
-2,180
Closed -$309K – 1115
2019
Q3 		$309K Buy
+2,180
New +$300K 0.01% 749
2016
Q2 		– Sell
-3,808
Closed -$264K – 772
2016
Q1 		$264K Buy
+3,808
New +$229K 0.04% 498

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sigma Planning Corp's WST Position: Q3 2024 in Review

Sigma Planning Corp sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 619 shares — an estimated $204K sold.

Sigma Planning Corp first reported a position in WST in Q1 2016 and held it in 9 quarters. The position peaked at $458K in Q3 2020. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Sigma Planning Corp reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Sigma Planning Corp sold 619 West Pharmaceutical shares in Q3 2024, an estimated $204K.
  • Sigma Planning Corp first reported a position in West Pharmaceutical in Q1 2016 and held it in 9 quarters.
  • Sigma Planning Corp's West Pharmaceutical position peaked at $458K in Q3 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Sigma Planning Corp's 13F filing for Q3 2024, filed 4 Nov 2024.